Kaya Limited is an India-based company engaged in providing skincare and hair care solutions through scientific dermatological procedures and products. Incorporated on March 27th, 2003, Kaya Ltd houses a range of Kaya Clinics in India with two business formats - Kaya Clinic, and Kaya E-commerce Site. The company started as a division of Marico Limited and later emerged as a separate entity, becoming independent following a demerger in September 2013.
Kaya Limited operates a chain of skin, hair and body care clinics in India and the Middle East, establishing itself as a prominent player in the aesthetic dermatology space. The company provides treatments across 78 clinics in 25 cities, offering specialized services designed to address various skin and hair concerns with scientific precision and expertise.
The company's comprehensive service portfolio spans multiple categories within the beauty and wellness sector. It provides a range of skin and hair care products and services, such as remedying acne, pigmentation, dull skin concerns, overall skin health, hair concerns and other everyday skin and hair needs. The Company offers approximately 80+ products, including acne, brightening, everyday essentials, anti-ageing, derma naturals, body care, hair care and beauty facials.
The company also provides skin services comprising laser hair, thermage, HIFU, dermal fillers, chemical peel, Q-switch laser, and skin brightening and lightening treatments; hair services, such as PRP GF treatment, PDO hair thread treatment, biocell hair therapy, intensive hair root therapy, and hair nutri-infusion therapy; and body contouring services consisting of Kaya wonder treatment, CM slim, Venus Legacy, and cool sculpting. The Company also sells skin and hair care products through stores, online and third-party outlets.
Kaya Ltd currently maintains a market cap of ₹567 Cr, positioning it as a significant player in India's growing aesthetic dermatology market. The company released its financial reports for the quarter ended March 31, 2025 (Q4 FY25), posting ₹7 crore profit in Q4 FY25, driven by strong clinic collections and AI-driven innovations.
The company reported Revenue of ₹217 Cr and Profit of ₹83.7 Cr for the full financial year, though it faces challenges with poor sales growth of -11.2% over the past five years.
- Q4 FY25 Performance: Clinic Net Revenue of ₹51.8 crore (up 3% YoY), Adjusted PAT loss of ₹7.1 crore (significant improvement from ₹95.1 crore loss in Q4 FY24).
- Discontinued Operations Profit (Kaya Middle East FZE & DMCC): ₹129.0 crore (sale concluded June & November 2024).
- Full Year Revenue: ₹217 Cr
- Full Year Profit: ₹83.7 Cr
- Market Capitalization: ₹567 Cr (as of 2025)
- Promoter Holding: 59.93% (as of March 2025)
Kaya's operational metrics demonstrate steady progress in customer acquisition and satisfaction. Clinic Customer Count reached 32,002, up from 30,258 YoY, indicating growing market acceptance. Net Promoter Score (NPS) rose to 89, indicating strong customer satisfaction, which reflects the quality of services provided and customer loyalty.
Anti-Ageing Services showed particularly strong performance with 46% YoY growth, highlighting the expanding demand for aesthetic treatments in India's evolving beauty and wellness market.
Kaya was honoured with the "Best Use of AI Technology" award at the 9th Future of Retail & E-commerce Awards 2025, presented by UBS Forums. This recognition underscores the company's commitment to integrating cutting-edge technology into its service delivery model. Kaya Limited has a partnership with Bien-Etre Ltd to develop a skin personalization platform using DNA biomarkers and AI.
Currently, the promoter group owns a 59.93% stake in Kaya, with Promoter holding decreasing slightly to 59.64 per cent as of Mar 2025 from 59.79 per cent as of Jun 2024. B S R & Co LLP serves as the auditor for Kaya Ltd.
The Board approved a preferential issue of 20.9 lakh shares at ₹358.84 each to raise ₹75 crore for expansion and corporate purposes in June 2025. The company aims to focus on innovations targeted at its customers and expand its reach to key metropolitan cities, targeting the expanding aesthetic dermatology market in India, projected to grow at a CAGR of 17% in FY26.
The strategic focus on metropolitan expansion and technology integration positions Kaya to capitalize on India's growing disposable income and increasing awareness about aesthetic treatments. With its established clinic network, comprehensive service portfolio, and commitment to innovation, Kaya Ltd remains well-positioned to capture growth opportunities in the evolving Indian beauty and wellness sector.
